Newsletter Edition 82
Aug 28, 2025
Eldridge Targets $1B for New GP Solutions Fund
Eldridge Capital Management, a subsidiary of New York-based asset manager Eldridge with $70 billion in AUM, is seeking to raise $1 billion for a new private equity vehicle focused on GP-led transactions, according to a Bloomberg report.
The fund will provide capital for continuation funds – structures that enable private equity sponsors to hold onto high-performing assets beyond traditional fund lifecycles while delivering liquidity to existing investors. It will also address broader financing needs in the GP-led secondaries market, which has seen rapid growth as managers adapt to a prolonged dealmaking slowdown.
Global private market secondaries volume hit $102 billion in H1 2025, a 41% year-on-year increase, according to data from Evercore. Eldridge’s push into this space follows the 2023 appointment of David Lee to lead its GP solutions strategy, marking a significant expansion into secondary investments.
The firm enters an increasingly competitive fundraising environment, with about $120 billion in secondaries capital currently being raised worldwide, according to With Intelligence.
If successful, the vehicle would position Eldridge among a growing group of managers capitalizing on market dislocation and rising demand for flexible liquidity solutions in private equity.
https://www.privateequitywire.co.uk/eldridge-targets-1bn-for-gp-solutions-fund/
Bain Capital Considers $1.4B Take-Private Offers for Canada Goose
Bain Capital is evaluating bids to take Canada Goose private in a deal that could value the luxury outerwear maker at around $1.4 billion, according to a CNBC report citing people familiar with the matter.
Bain, which first invested in the Toronto- and New York-listed company in 2013 and remains its controlling shareholder, has hired Goldman Sachs to advise on the process. A decision is expected only after additional bids are received. Canada Goose currently has a market capitalisation of about $1.18 billion, according to LSEG data.
Private equity groups Advent International and Boyu Capital have submitted indicative offers, while strategic suitors – including China’s Bosideng International and a consortium led by Anta Sports and FountainVest Capital – are also reportedly exploring a deal.
A sale would conclude Bain’s decade-long investment, during which Canada Goose transformed from a niche parka manufacturer into a global luxury lifestyle brand. However, recent performance has been uneven: the company reported a larger-than-expected quarterly loss in July, citing expansion costs and higher promotional spending, and withheld fiscal 2026 guidance due to tariff uncertainty.
Neither Bain Capital nor Canada Goose has commented publicly on the reported offers.
GTCR in Talks With Private Lenders to Back Potential €5B Zentiva Buyout
Chicago-based private equity firm GTCR is in discussions with direct lenders, including KKR, to arrange financing for a potential acquisition of European generics manufacturer Zentiva, Bloomberg reported, citing people familiar with the matter.
The talks are ongoing and may not lead to a transaction, but a successful bid could value Zentiva at around €5 billion ($5.8 billion). Other suitors previously reported to have explored offers include TPG and India’s Aurobindo Pharma.
Advent International, which acquired Zentiva from Sanofi in 2018 for €1.9 billion, has grown the platform into a major supplier of generics across Europe, producing more than 500 products in 900 formulations that span therapeutic areas from blood disorders to pain relief. Advent engaged Goldman Sachs and PJT Partners last year to evaluate strategic options, including a sale.
A buyout of Zentiva would mark one of Europe’s largest healthcare private equity deals this year and underscores the rising role of private credit financing in multi-billion-euro transactions. Direct lenders are increasingly being tapped by sponsors seeking speed and flexibility over volatile syndicated loan and bond markets.
The potential deal comes amid a broader rebound in global M&A, with $2.7 trillion of transactions announced so far in 2025 – a 25% increase compared with the same period last year, according to Bloomberg data.